To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:204 Issue:1 Number:1 ISSN#:2564-2537
ACE Report #14244
Ace Report Cover Trauma

Dexmedetomidine Infusion in Hip Fracture Surgery

How to Cite

OrthoEvidence. Dexmedetomidine Infusion in Hip Fracture Surgery. ACE Report. 2022;204(1):1. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effect of Dexmedetomidine infusion during hip fracture surgery on hemodynamic parameters and blood loss: A triple-blinded Randomized Clinical Trial.

Injury . 2022 Feb;53(2):551-554.

Contributing Authors:
E Hazrati F Vosoughi M Chamanara H Teymourian

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seventy six patients undergoing hip fracture surgery under general anesthesia were randomized to receive an intraoperative dexmedetomidine infusion (n=38) or placebo infusion (n=38). The outcomes of interest were blood loss and hemodynamic parameters. The dexmedetomidine group had significantly lower blood loss compared to the placebo group. No differences in hemodynamic parameters were observed b...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.